https://www.pharmacytimes.com/view/fda-approves-nirsevimab-alip-to-prevent-rsv-in-infants-toddlers
0
0
7/17/23 at 7:58pm
Organization
Pharmacytimes.com
The approval marks the first monoclonal antibody approved to protect all infants through their first respiratory syncytial virus season.
Create an account
or login to join the discussion